FdaApplication
NDA 022172
Identifiers
- fda_app_no: NDA022172
Properties
| Property | Value |
|---|---|
| applicant_name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| application_type | NDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEROQUEL XR | QUETIAPINE FUMARATE | 50MG | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | 400MG | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | 200MG | TABLET, EXTENDED RELEASE;ORAL |
| SEROQUEL XR | QUETIAPINE FUMARATE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
4 products